Commonwealth Equity Services, LLC Gossamer Bio, Inc. Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 34,471 shares of GOSS stock, worth $29,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,471
Previous 31,171
10.59%
Holding current value
$29,300
Previous $28,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$15.4 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$11.3 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$9.99 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.81 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.85 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $79.9M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...